Alar Pharmaceuticals Inc. (6785.TWO)

TWD 122.0

(2.09%)

Total Assets Summary of Alar Pharmaceuticals Inc.

  • Alar Pharmaceuticals Inc.'s latest annual total assets in 2023 was 973.2 Million TWD , up 86.22% from previous year.
  • Alar Pharmaceuticals Inc.'s latest quarterly total assets in 2024 Q2 was 2.55 Billion TWD , down -4.27% from previous quarter.
  • Alar Pharmaceuticals Inc. reported annual total assets of 522.6 Million TWD in 2022, down -3.2% from previous year.
  • Alar Pharmaceuticals Inc. reported annual total assets of 539.9 Million TWD in 2021, down -10.61% from previous year.
  • Alar Pharmaceuticals Inc. reported quarterly total assets of 2.55 Billion TWD for 2024 Q2, down -4.27% from previous quarter.
  • Alar Pharmaceuticals Inc. reported quarterly total assets of 669.61 Million TWD for 2023 Q3, up 0.23% from previous quarter.

Annual Total Assets Chart of Alar Pharmaceuticals Inc. (2023 - 2019)

Historical Annual Total Assets of Alar Pharmaceuticals Inc. (2023 - 2019)

Year Total Assets Total Assets Growth
2023 973.2 Million TWD 86.22%
2022 522.6 Million TWD -3.2%
2021 539.9 Million TWD -10.61%
2020 603.97 Million TWD 0.0%
2019 - TWD 0.0%

Peer Total Assets Comparison of Alar Pharmaceuticals Inc.

Name Total Assets Total Assets Difference
Allied Biotech Corporation 2.07 Billion TWD 53.187%
GeneFerm Biotechnology Co., Ltd. 1.17 Billion TWD 17.2%
Easywell Biomedicals, Inc. 1.21 Billion TWD 19.82%
TTY Biopharm Company Limited 9.87 Billion TWD 90.145%
Synmosa Biopharma Corporation 11.72 Billion TWD 91.702%
Orient EuroPharma Co., Ltd. 10.81 Billion TWD 90.999%
Center Laboratories, Inc. 27 Billion TWD 96.396%
Tien Liang BioTech Co., Ltd. 654.03 Million TWD -48.8%
Orient Pharma Co., Ltd. 2.56 Billion TWD 62.024%
InnoPharmax Inc. 524.19 Million TWD -85.657%
Johnson Chemical Pharmaceutical Works Co., Ltd. 1.99 Billion TWD 51.167%
Excelsior Biopharma Inc. 1.57 Billion TWD 38.3%
DV Biomed Co., Ltd. 1.81 Billion TWD 46.31%
Foresee Pharmaceuticals Co., Ltd. 1.86 Billion TWD 47.718%
Handa Pharmaceuticals, Inc. 3.03 Billion TWD 67.957%
UniPharma Co., Ltd. 350.07 Million TWD -178.0%
Anxo Pharmaceutical Co., Ltd. 2.21 Billion TWD 56.134%
Winston Medical Supply Co., Ltd. 801.77 Million TWD -21.381%
Mercury Biopharmaceutical Corporation 438.07 Million TWD -122.155%
Bioray Biotech Co., Ltd 542.64 Million TWD -79.344%
TSH Biopharm Corporation Limited 1.39 Billion TWD 30.478%